Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Characterization of the CD8 T cell response in elite control of HIV infection

FY 2023-24

Summary
Less than 1% of individuals infected with human immunodeficiency virus (HIV) are elite controllers (EC), individuals who naturally control HIV replication. In most people living with HIV (PLWH), combined antiretroviral therapy controls HIV replication and disease progression. However, PLWH experience disease progression with treatment discontinuation because of viral reactivation in reservoirs that harbour HIV, such as CD4+ T cells. Though CD4+ T cells can be targeted by the host immune response through cytotoxic T lymphocytes (CTL), vaccination to induce CTL responses against HIV reservoirs have not been successful. However, vaccination by targeting of patient type specific tumor identifiers (i.e., epitopes) to induce CTL responses are effective in reducing metastatic events in cancer. As ECs have strong HIV-specific CTL responses, we hypothesize that patient specific epitopes based on ECs can be used to target the reservoir. We aim to characterize CTL response inducing, patient specific epitopes from an EC. We will first identify potential CTL response inducing epitopes from an EC using an immunoassay to determine which epitopes result in the secretion of antiviral CTL products from ECs. We will then determine which of these identified epitopes are specific to the EC patient type. Finally, we will confirm CTL response inducing epitopes using an immunoassay to validate their secretion of antiviral CTL products, and their ability to kill HIV infected CD4+ T cells. By characterizing the CTL response inducing, patient specific epitopes from an EC, we will gain insight into which epitopes should be considered for a therapeutic vaccine. This will advance research into HIV reservoir eradication and disease control in PLWH.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506293
Name
Udayakumar Suji
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of the CD8 T cell response in elite control of HIV infection
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cd8; Elite Control; Epitope; Hiv; Reservoir
Abstract
Less than 1% of individuals infected with human immunodeficiency virus (HIV) are elite controllers (EC), individuals who naturally control HIV replication. In most people living with HIV (PLWH), combined antiretroviral therapy controls HIV replication and disease progression. However, PLWH experience disease progression with treatment discontinuation because of viral reactivation in reservoirs that harbour HIV, such as CD4+ T cells. Though CD4+ T cells can be targeted by the host immune response through cytotoxic T lymphocytes (CTL), vaccination to induce CTL responses against HIV reservoirs have not been successful. However, vaccination by targeting of patient type specific tumor identifiers (i.e., epitopes) to induce CTL responses are effective in reducing metastatic events in cancer. As ECs have strong HIV-specific CTL responses, we hypothesize that patient specific epitopes based on ECs can be used to target the reservoir. We aim to characterize CTL response inducing, patient specific epitopes from an EC. We will first identify potential CTL response inducing epitopes from an EC using an immunoassay to determine which epitopes result in the secretion of antiviral CTL products from ECs. We will then determine which of these identified epitopes are specific to the EC patient type. Finally, we will confirm CTL response inducing epitopes using an immunoassay to validate their secretion of antiviral CTL products, and their ability to kill HIV infected CD4+ T cells. By characterizing the CTL response inducing, patient specific epitopes from an EC, we will gain insight into which epitopes should be considered for a therapeutic vaccine. This will advance research into HIV reservoir eradication and disease control in PLWH.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Udayakumar, Suji
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~